Ignite Creation Date:
2024-05-06 @ 2:20 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04280354
Status:
TERMINATED
Last Update Posted:
2024-05-09
First Post:
2020-02-19
Brief Title:
Molecular Biomarkers for Sepsis
Sponsor:
University Hospital Basel Switzerland
Organization:
University Hospital Basel Switzerland
Study Overview
Official Title:
Prospective Study to Discover New Biomarkers for Early Detection of Sepsis and Prediction of Sepsis-related Mortality in Patients With Severe Community Acquired Pneumonia sCAP
Status:
TERMINATED
Status Verified Date:
2024-05
Last Known Status:
Recruiting
Delayed Posting:
No
If Stopped, Why?:
Recruitment failure
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This multi-center observational case-control study in Intensive Care Unit ICU patients is to identify novel biomarkers allowing to recognize severe community acquired pneumonia sCAP -associated sepsis at an earlier stage and predict sepsis-related mortality Patients with sCAP cases will be profoundly characterized over time regarding the development of sepsis and compared with control patients The mechanisms and influencing factors on the clinical course will be explored with most modern -omics technologies allowing a detailed characterisation These data will be analysed using machine learning algorithms and multi-dimensional mathematical models
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None